F18.24
Inhalant dependence with inhalant-induced mood disorder
Clinical Classification Guidelines
Inclusion Terms
- Inhalant use disorder, moderate, with inhalant induced depressive disorder
- Inhalant use disorder, severe, with inhalant induced depressive disorder
Medical Intelligence & Overview
ICD-10 code F18.24 refers to a condition where an individual is dependent on inhalants and also experiences mood disturbances due to inhalant use. This combination signifies a complex substance use disorder that impacts both psychological and emotional well-being. Inhalant dependence can escalate to severe levels, often accompanied by depressive symptoms that are directly induced by inhalant use. Recognizing this condition is crucial for appropriate treatment and management, as it involves both substance dependence and mood disorders that influence the patient's daily functioning.
Causes & Symptoms
Clinical Causes: Prolonged or repeated use of inhalant substances like solvents, aerosols, or nitrites. Genetic predisposition to substance dependence. Psychological factors such as stress, trauma, or mental health issues that may lead to inhalant use. Environmental influences, including peer pressure, availability of inhalants, and socioeconomic challenges. Underlying mood disorders that may lead to or exacerbate inhalant use as a form of self-medication.
Key Symptoms: Dependence on inhalants, characterized by a strong desire or craving to use the substance. Increased tolerance, requiring larger amounts to achieve the desired effect. Withdrawal symptoms when not using inhalants, such as anxiety or irritability. Mood disturbances, including persistent depressive feelings or mood swings. Impaired judgment or coordination. Physical signs like dizziness, slurred speech, or chemical odor on breath or clothing. Neglect of personal or professional responsibilities due to inhalant use.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves comprehensive clinical assessment, including detailed patient history and physical examination. Healthcare providers evaluate patterns of inhalant use, dependence symptoms, and mood disturbances. Standardized screening tools for substance use disorder and mood disorders may be utilized. Laboratory tests are not definitive for inhalant dependence but can help rule out other causes. Mental health evaluations are essential to understand the extent of mood symptoms and their impact on functioning.
Treatment Protocols: Detoxification and withdrawal management under medical supervision. Psychotherapy, such as cognitive-behavioral therapy (CBT), to address dependence and underlying emotional issues. Medication-assisted treatment may be considered for mood stabilization or to reduce cravings. Support groups and peer counseling for ongoing support. Addressing co-occurring mental health conditions to improve overall outcomes. Lifestyle modifications and support systems to prevent relapse.
Clinical Advice & FAQs
Billing Guidance
Is F18.24 a billable ICD-10 code?
Yes, F18.24 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F18.24?
Clinical documentation must specify the nature of Inhalant dependence with inhalant-induced mood disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference